Article
Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV.
Virology journal - 18 Sept 2020
Mosa Alexander I, AbouHaidar Mounir G, Urbanowicz Richard A, Tavis John E, Ball Jonathan K, Feld Jordan J
Abstract excerpt
Despite available treatments, a prophylactic HCV vaccine is needed to achieve elimination targets. HCV vaccine development has faltered largely because the extreme diversity of the virus limits the protective breadth of vaccine elicited antibodies. It is believed that the principle neutralizing epitope in natural infection, HVR1, which is the most variable epitope in HCV, mediates humoral immune escape. So far,...
Topics
- Animals
- Antibodies, Neutralizing
- Antibodies, Viral
- Cross Reactions
- Epitopes, B-Lymphocyte
- Female
- Genotype
- Hepacivirus
- Hepatitis C
- Hepatitis C Antibodies
- Humans
- Mice
- Mice, Inbred BALB C
- Neutralization Tests
- Viral Proteins
